Stock analysts at Credit Suisse Group AG began coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a research report issued on Thursday. The brokerage set a “neutral” rating and a $35.00 price target on the stock. Credit Suisse Group AG’s price objective would suggest a potential upside of 11.61% from the stock’s previous close.

Several other equities analysts have also issued reports on ACHC. BMO Capital Markets decreased their price target on shares of Acadia Healthcare from $52.00 to $48.00 and set an “outperform” rating for the company in a report on Thursday, October 26th. Robert W. Baird lowered shares of Acadia Healthcare from an “outperform” rating to a “neutral” rating and decreased their price target for the company from $55.00 to $38.00 in a report on Wednesday, October 25th. Jefferies Group LLC set a $42.00 price target on shares of Acadia Healthcare and gave the company a “buy” rating in a report on Wednesday, October 25th. Bank of America Corporation decreased their price target on shares of Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a report on Wednesday, October 25th. Finally, Mizuho lowered shares of Acadia Healthcare from a “buy” rating to a “neutral” rating and set a $36.00 price target for the company. in a report on Sunday. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $46.57.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, October 24th. The company reported $0.58 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.07). Acadia Healthcare had a return on equity of 8.57% and a net margin of 6.07%. The business had revenue of $716.70 million for the quarter, compared to analyst estimates of $728.86 million. During the same period in the prior year, the firm posted $0.58 EPS. Acadia Healthcare’s revenue was down 2.4% on a year-over-year basis.

TRADEMARK VIOLATION WARNING: “Acadia Healthcare Company, Inc. (ACHC) Coverage Initiated at Credit Suisse Group AG” was reported by American Banking News and is the property of of American Banking News. If you are reading this report on another publication, it was stolen and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2017/11/02/acadia-healthcare-company-inc-achc-coverage-initiated-at-credit-suisse-group-ag.html.

In other Acadia Healthcare news, EVP Christopher L. Howard sold 53,713 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total transaction of $2,722,711.97. Following the sale, the executive vice president now directly owns 147,286 shares of the company’s stock, valued at approximately $7,465,927.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, President Brent Turner sold 206,252 shares of the business’s stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the sale, the president now directly owns 81,106 shares in the company, valued at $4,111,263.14. The disclosure for this sale can be found here. Insiders have sold a total of 1,826,040 shares of company stock worth $92,564,008 over the last three months. Insiders own 11.10% of the company’s stock.

Large investors have recently modified their holdings of the business. Advisory Services Network LLC lifted its position in Acadia Healthcare by 5,542.1% during the 3rd quarter. Advisory Services Network LLC now owns 2,144 shares of the company’s stock worth $106,000 after buying an additional 2,106 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Acadia Healthcare by 11.1% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock worth $134,000 after buying an additional 270 shares in the last quarter. Seven Eight Capital LP bought a new stake in Acadia Healthcare during the 4th quarter worth about $152,000. Pacad Investment Ltd. bought a new stake in Acadia Healthcare during the 4th quarter worth about $166,000. Finally, Advisors Asset Management Inc. lifted its position in Acadia Healthcare by 553.9% during the 3rd quarter. Advisors Asset Management Inc. now owns 3,760 shares of the company’s stock worth $186,000 after buying an additional 3,185 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.